Loading clinical trials...
Loading clinical trials...
The purpose of the study is to evaluate if LiRIS 400 mg is safe and tolerable when administered to women with Interstitial Cystitis with Hunner's lesions, and to evaluate any change in the bladder or ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Allergan
Collaborators
NCT05149573 · Interstitial Cystitis, Chronic Interstitial Cystitis, and more
NCT06013449 · Interstitial Cystitis, Chronic Interstitial Cystitis, and more
NCT04275297 · Chronic Interstitial Cystitis, Bladder Pain Syndrome, and more
NCT04540887 · Interstitial Cystitis, Chronic Interstitial Cystitis, and more
Advance Urology Institute
Daytona Beach, Florida
William Beaumont Hospital
Royal Oak, Michigan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions